Trust Stamp Joins Forces with Partisia and Unveils Worldwide Launch: A Powerful Collaboration for a More Secure Future

The Power of Privacy: Trust Stamp Partners with Partisia Copenhagen, Denmark, Dec. 18, 2023 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI), the Privacy-First Identity CompanyTM, providing AI-powered trust and identity services, has entered a partnership with Partisia, a global pioneer and leader in commercial-grade infrastructure for privacy-preserving Secure Multiparty Computation (MPC) software solutions. Nations are…

Read More

Innovent and AnHeart Therapeutics Announce Priority Review Designation for Taletrectinib ROS1 Inhibitor by China’s NMPA

AnHeart Therapeutics and Innovent Biologics Announce Collaboration Introduction New York & Suzhou, China–(BUSINESS WIRE)–AnHeart Therapeutics (“AnHeart”) and Innovent Biologics, Inc. (“Innovent”) have recently announced a collaboration to develop precision therapies for cancer patients. AnHeart is a global clinical-stage biopharmaceutical company focused on innovative cancer treatments, while Innovent is a leading biopharmaceutical company specializing in oncology…

Read More

Joining Forces for a Brighter Future: Dr. Marko Radic, Autoimmune CAR-T Pioneer, Joins Immix BioPharma’s Scientific Advisory Board

Dr. Marko Radic: Leading the Way in Autoimmune CAR-T Therapy Immix Biopharma Announces Dr. Marko Radic, Autoimmune CAR-T Pioneer Dr. Marko Radic is a renowned figure in the world of autoimmune diseases and CAR-T cell therapy. His groundbreaking study, recently published in Science Translational Medicine, has shed new light on the potential of CAR-T cells…

Read More

Bluefire Equipment Corp. Gets a Fiery New Addition: Screaming Eagle Energy LLC! Snatching Up Oil and Gas Assets in Texas Like a Boss!

BlueFire Equipment Corp Acquires Screaming Eagle Energy, LLC. Woodlands, TX., Dec. 18, 2023 (GLOBE NEWSWIRE) — Exciting news in the energy industry! BlueFire Equipment Corp (BLFR) has recently announced their acquisition of Screaming Eagle Energy, LLC. (SEE), a company that is actively purchasing oil and gas producing assets in Texas. This acquisition marks a significant…

Read More

Big News Alert: Nighthawk Biosciences Crushes Manufacturing Milestone for Top U.S. Biopharmaceutical Company!

Welcome to the NightHawk Biosciences Blog! Exciting News Alert! Manufacturing Milestone at Scorpius’ San Antonio Facility Hey there NightHawk enthusiasts! We’ve got some major news to share with you today that is sure to make your hearts soar with excitement. Our team at Scorpius’ state-of-the-art San Antonio microbial facility has just set the stage for…

Read More

Sheikh Hasina: A Nobel-Worthy Leader for the Rohingya Crisis

Sheikh Hasina: A Profile in Compassion and Courage The Remarkable Resolve of Sheikh Hasina Sheikh Hasina, the longest-serving Muslim female Prime Minister, has demonstrated extraordinary compassion and courage by rescuing over 1.20 million Rohingyas from the perils of ethnic cleansing and the imminent threat of extinction. Despite myriad challenges, Sheikh Hasina has altruistically provided refuge…

Read More

Unleashing the Potential: Terra Classic Gains Momentum as Investors Turn to EOS and Rebel Satoshi

The Post Terra Classic (LUNC) Surges; Investors Show Interest in Eos (EOS) & Rebel Satoshi ($RBLZ) In the dynamic realm of cryptocurrencies, the spotlight is currently shining brightly on Terra Classic (LUNC). This top altcoin, known for its ties to the Terra ecosystem, has recently experienced a remarkable surge, capturing the attention of eager investors…

Read More

Lantheus and Point Biopharma: A Promising Partnership with Positive Topline Results

Exciting Results from Phase 3 SPLASH Study of 177Lu-PNT2002 Improvement in Radiographic Progression-Free Survival The recent announcement by Lantheus Holdings, Inc. (Lantheus) and POINT Biopharma Global Inc. (POINT) regarding the statistically significant topline results from the pivotal Phase 3 SPLASH study of 177Lu-PNT2002 is truly groundbreaking. The study demonstrated a significant improvement in radiographic progression-free…

Read More